Inozyme Pharma rises on $73 mln common stock, warrants offering

Inozyme Pharma

14/04/2022 18:55

** Biopharmaceutical company's shares  INZY.O  rise 10.7% to
$4.08
    ** Co prices underwritten offering of shares and warrants
for gross proceeds of about $73 mln  urn:newsml:reuters.com:*:nGNXC17SQ
    ** Offering expected to close on or about April 19
    ** Jefferies LLC and Cowen and Co, LLC are acting as joint
book-running managers for the offering
    ** Stock down 40.1% this year, including session moves

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))